SEQUANA MEDICAL ANNOUNCES DECISION OF MAJOR SHAREHOLDERS TO INVEST IN SECOND TRANCHE OF CONVERTIBLE BRIDGE LOAN Ghent, Belgium, 6 December 2024 – (Euronext Brussels: SEQUA) (the "Company" or "Sequana ...

Ovarian cancer took my beautiful mum, and it makes me angry – angry that in this century, treatment options have barely ...

When you hear about hepatitis A, you may think of tainted food and water, but this liver infection can also be spread from ...

Switch Therapeutics Inc. has announced its first development candidate, a liver-sparing APOE (apolipoprotein E) RNAi therapy for treatment of Alzheimer’s disease in APOE4 carriers. Switch’s ...

James Marlin stood at a crossroads. After a 25-year career in the medical field, primarily in orthopedic sales and surgical ...

Discover a study that examined the efficacy and safety of pemafibrate in 360 patients with MASLD and hypertriglyceridaemia.

In 2021, alcohol-related liver cirrhosis accounted for about a quarter of the 46·4 million disability-adjusted life-years (DALYs) lost from liver disease globally, making alcohol a leading cause of ...

Research reports that in the United States, the number of patients who underwent bariatric procedure decreased by 25%, while ...

Background: Hepatoblastoma, a prevalent malignant liver tumor in children, presents significant management challenges in ...

AKI - the other main type of kidney disease - can be caused by dehydration, blood loss, urinary tract obstructions such as ...

Explore how E-selectin-targeted polymer-doxorubicin therapy induces regression in colorectal liver metastases.

As the largest internal organ in the human body, the liver supports a wide range of responsibilities related to metabolism, ...